Lexicon Pharmaceuticals, Inc. Common Stock (NASDAQ: LXRX) last traded at $2.30, up 5.50% on the session. The quote above updates while this page is open; the figures below are drawn from Lexicon Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Lexicon Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker LXRX. Its market capitalisation is $1.02 billion.
Valuation measures for Lexicon Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.02B |
|---|---|
| Enterprise value | $1.06B |
| Price / sales | 24.68 |
| Price / book | 5.86 |
| Beta | 1.41 |
Trailing-twelve-month figures tagged in Lexicon Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $41.47M |
|---|---|
| Net income (TTM) | -$61.12M |
| EPS (TTM) | -$0.150 |
| Operating margin | -131.43% |
| Return on equity | -35.02% |
| Cash | $40.92M |
Range and volume for LXRX over the past 52 weeks.
| 52-week high | $2.68 |
|---|---|
| 52-week low | $1.03 |
| Volume | 3.16M |
| Average volume | 3.30M |
| Previous close | $2.18 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.